文献速递泌尿男性生殖肿瘤

基因组检测对非裔美国有利风险前列腺癌治疗决策的影响:随机试验

Impact of a Genomic Test on Treatment Decision in a Predominantly African American Population With Favorable-Risk Prostate Cancer: A Randomized Trial.
PubMed 文献 · J Clin Oncol · 2021-04-09

结果显示AS接受率总体较高,但干预组略低(77% vs 88%;

要点

  • GPS检测未提高AS接受率,反而使部分患者远离AS。
  • 低健康素养男性接受GPS后选择AS的可能性显著降低。
  • 低中危患者中69%的GPS结果提示不利中危或高危。

核心结论

  • GPS检测的净效应是使患者远离主动监测(AS),主要见于低健康素养男性。

研究设计与样本

  • 患者随机分配至标准咨询联合或不联合12基因GPS检测。
  • 主要终点为第二次诊断后访视时的治疗选择。

主要发现

  • 低中危风险患者中69%的GPS值提示不利中危或高危癌症。
  • AS选择与前列腺癌家族史和拥有健康保险独立相关。

临床怎么用

  • 对低健康素养的前列腺癌患者,应谨慎解读GPS结果以避免过度影响治疗决策。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: The Genomic Prostate Score (GPS), performed on biopsy tissue, predicts adverse outcome in prostate cancer (PCa) and has shown promise for improving patient selection for active surveillance (AS). However, its impact on treatment choice in high-risk populations of African Americans is largely unknown and, in general, the effect of the GPS on this difficult decision has not been evaluated in randomized trials. METHODS: Two hundred men with National Comprehensive Cancer Network very low to low-intermediate PCa from three Chicago hospitals (70% Black, 16% college graduates) were randomly assigned at diagnosis to standard counseling with or without a 12-gene GPS assay. The primary end point was treatment choice at a second postdiagnosis visit. The proportion of patients choosing AS was compared, and multivariable modeling was used to estimate the effects of various factors on AS acceptance. RESULTS: AS acceptance was high overall, although marginally lower in the intervention group (77% v 88%; P = .067), and lower still when men with inadequate specimens were excluded (P = .029). Men with lower health literacy who received a GPS were seven-fold less likely to choose AS compared with controls, whereas no difference was seen in men with higher health literacy (Pinteraction = .022). Among men with low-intermediate risk, 69% had GPS values consistent with unfavorable intermediate or high-risk cancer. AS choice was also independently associated with a family history of PCa and having health insurance. CONCLUSION: In contrast to other studies, the net effect of the GPS was to move patients away from AS, primarily among men with low health literacy. These findings have implications for our understanding of how prognostic molecular assays that generate probabilities of poor outcome can affect treatment decisions in diverse clinical populations.

来源:J Clin Oncol,查看原文。版权归原作者所有。

引用

  1. Murphy AB, Abern MR, Liu L, et al. Impact of a Genomic Test on Treatment Decision in a Predominantly African American Population With Favorable-Risk Prostate Cancer: A Randomized Trial. J Clin Oncol. 2021. PMID: 33835822. doi:10.1200/JCO.20.02997

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。